WRITTEN BY
We are excited to welcome Quris-AI, the latest company to join the AstraZeneca BioVentureHub at the Gothenburg R&D site.
Quris-AI combines Bio and AI capabilities to provide safer, more effective, and more personalized drugs to patients faster, leveraging their patented AI-driven patient-on-chip platform.
Led by a team of pioneers in machine learning, big data, organ-on-chip, biotech, genomics, technology and pharma, Quris brings together the best of both worlds: Bio and AI.
By joining the BioVentureHub, Quris will form a growing team situated at the AZ Gothenburg R&D site in Sweden, with access to state-of-the-art facilities, infrastructure, R&D knowledge, and expertise.
Dr. Isaac Bentwich, CEO of Quris, expressed his enthusiasm: “Joining this vibrant ecosystem offers an extraordinary opportunity for us and the industry at large. We are creating a regional stronghold for our European AI hub, teeming with knowledge and expertise. Additionally, we gain the benefits of a community that fosters innovation and provides the necessary infrastructure for long-term success.
We are eager to collaboratively forge unprecedented advancements that revolutionize drug development as Quris brings its novel approach to the global market.”
"AstraZeneca BioVentureHub is equally thrilled about this partnership. Quris exemplifies what can be achieved by combining Bio and AI, with a clear ambition to redefine healthcare.
The collaboration with Quris is a result of global collaborations efforts with companies and ecosystems, which has been initiated and supported by AstraZeneca, A.Catalyst Network of innovation hub worldwide. In this case with BeyondBio - by AstraZeneca, with the SCALE program, in which Quris participated.
Together, we strive to scale at the intersection of life science, data & AI, and technology."
Magnus Björsne, Head of BioVenture Innovation Unit, AstraZeneca
The Quris Team: Amit Cohen, Dr. Amir Bein, Dr. Isaac Bentwich, Yarin Lowenhardt, Shahar Harel, Dr. Shelly Maman.
Sharon Ein Gal, Head of BeyondBio, AstraZeneca and Magnus Björsne, Head of BioVenture Innovation Unit, AstraZeneca.
Please read more about Quris AI here: https://www.quris.ai/
Read more about A.Catalyst Network by AstraZeneca: https://www.astrazeneca.com/partnering/a-catalyst-network.html
Read more about BeyondBio by AstraZeneca: https://www.beyondbio.co.il/
Take a look at AstraZeneca BioVentureHub on Linkedin: LinkedIn